PathoPulse ApS: Financial statements 2024
CVR: 42004405
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PathoPulse ApS (CVR 42004405) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 415,287 and a net result of DKK 309,665 compared with DKK -52,882 the year before. Equity in the 2024 report amounted to DKK 814,628. The solvency ratio was 89.8%.
- Gross Profit
- DKK 415,287
- Profit/Loss
- DKK 309,665
- Equity
- DKK 814,628
- Total Assets
- DKK 906,695
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 415 t. | 310 t. | 815 t. | - |
| 2023 | - | - | -53 t. | 505 t. | - |
| 2022 | - | - | 345 t. | 557 t. | - |
| 2021 | - | 386 t. | 172 t. | 212 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PathoPulse ApS has published its annual report for 2023. The net result was DKK -52,882.
About PathoPulse ApS
PathoPulse ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2021. The company is registered under the industry IT-infrastruktur, databehandling, hosting og relaterede aktiviteter. The management consists of Andreas Schønau. The company is owned by PathoPulse Holding ApS. In 2025, the company reported a gross profit of DKK 1,162,212 and a net result of DKK 181,104 compared with DKK 309,665 the year before. Equity in the 2025 report amounted to DKK 996,353.